InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Hallock Kenneth, Director. Director active across 1 company, notably Greenwich LifeSciences, Inc.. In total, 2 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €9k. History available since 21 January 2022. The latest transaction was disclosed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
300 shares@ US$16.320.0011% mcap50.0% of flowCommon StockSEC:0001493152-22-002020:0
Ideal exit: 18 Oct 2022 (T+270)
300 shares@ US$16.320.0011% mcap100.0% of flowCommon StockSEC:0001493152-22-002020
Ideal exit: 18 Oct 2022 (T+270)
2 of 2 declarations
About Hallock Kenneth
Kenneth Hallock is a Director at Greenwich LifeSciences, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. With expertise in the life sciences field, he brings valuable insights to the board, contributing to the company's strategic direction.
